Tag: regulated drug testing
Common questions about the FMCSA Clearinghouse
In an effort to provide insight, information, and clarity about the upcoming database, we have compiled the most frequently asked questions.
Staying compliant with new DOT regulations
New DOT regulations add four opioids: hydrocodone, oxycodone, hydromorphone, and oxymorphone to the test panel. Our experts answer your questions.
Important changes with eCCF
eCCF impacts the entire federally-regulated drug testing process. Read about important changes and how they can affect your drug testing program.
Speed up testing with eCCF
Employers can begin taking advantage of eCCF for their DOT urine drug testing.
Quest Diagnostics Approved to Use eCCF for Federally-Mandated Workforce
Benefits of eCCF include fewer data entry and legibility issues, reduced collection site flaws, less paper to manage and improved overall efficiency.
Collection sites outfitted for eCCF
We have equipped our drug test collection sites with technology for eCCF and trained collectors to be proficient in all regulated requirements.
Electronic Chain of Custody Forms and regulated testing
eCCF advantages include fewer data entry and legibility errors, reduced paper consumption, and specimen tracking throughout the testing process.
Client forum reinforces ‘We’re There’ commitment
Bob McCormick, Vice President, Quest Diagnostics Employer Solutions, spoke to clients about the value of sharing ideas and best practices.
New to drug testing: Designated Employer Representative
The DER is the point of contact between the employer, donor and drug testing provider, and they receive drug test results on behalf of the employer.
Medical marijuana
The following article was published by the U.S. Department of Transportation Office of Drug & Alcohol Policy & Compliance (ODAPC).
